A
Atossa Therapeutics (ATOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atossa Therapeutics (ATOS)
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing medicines in areas of unmet medical need in oncology with a focus on breast cancer. The Company’s lead drug candidate under development is oral (Z)-endoxifen, which th... Read more
- USD0.88
- USD0.91
- USD0.83
- USD1.66
- 4.80%
- --
- 757.49k
- 1.24M
- 114M
- 0.55
- -22.90%
Stock News
yesterday
Jim Cramer explains how younger buyers are driving market action
CNBC
yesterday
Despite tariffs, Andy Jassy says Amazon hasn't 'seen prices appreciably go up,' so far
CNBC
yesterday
Cristiano Ronaldo’s new $700 million contract reportedly includes private-jet credits and personal staff. Here’s how that compares with perks for other top athletes and CEOs.
MarketWatch
yesterday
LGBTQ+ entrepreneurs starting businesses in record numbers
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
